Tyrosine-protein kinase transforming protein Abl

BE0001902ProteinAbelson murine leukemia virusABL

Tyrosine-protein kinase transforming protein Abl (Abelson murine leukemia virus) is a protein target in DrugBank. It is acted on by 4 drugs in DrugBank.

Gene name
ABL
UniProtKB entry
P00521Swiss-Prot
Residues / weight
746 residues · 81,871 Da
Also known as
2.7.10.2 · V-abl

Resolves to

Protein
UniProtP00521UniProt nameABL_MLVAB
Drugs

What you can answer from here — as of September 07, 2019

4DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
1Clinical trialTrials of drugs acting on it, by phase and status
Sign in
2GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
8+ReferencesStructured and connected to the statements they support
Sign in

Which compounds in development act on Tyrosine-protein kinase transforming protein Abl, and which indications are they being tested in?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In